These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38302784)

  • 1. Impact of intravitreal anti-VEGF therapy on intraretinal microvascular abnormalities in proliferative diabetic retinopathy.
    De Geronimo D; Parravano M; Sacconi R; Fragiotta S; Giannini D; Costanzo E; Varano M; Querques G
    Acta Diabetol; 2024 Apr; 61(4):525-528. PubMed ID: 38302784
    [No Abstract]   [Full Text] [Related]  

  • 2. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.
    Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK
    Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
    Alagorie AR; Nittala MG; Velaga S; Zhou B; Rusakevich AM; Wykoff CC; Sadda SR
    JAMA Ophthalmol; 2020 Aug; 138(8):851-857. PubMed ID: 32584384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
    Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
    Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of macular vascular density and foveal avascular zone changes by optical coherence tomography angiography (OCT-A) after intravitreal dexamethasone implant in diabetic macular edema resistant to Anti-VEGF treatment.
    Ceylan A; Dogan ME; Demircan A; Akar Y
    Int Ophthalmol; 2022 Nov; 42(11):3579-3588. PubMed ID: 35737210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.
    Ishibazawa A; Nagaoka T; Takahashi A; Omae T; Tani T; Sogawa K; Yokota H; Yoshida A
    Am J Ophthalmol; 2015 Jul; 160(1):35-44.e1. PubMed ID: 25896459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NEW BIOMARKER QUANTIFYING THE EFFECT OF ANTI-VEGF THERAPY IN EYES WITH PROLIFERATIVE DIABETIC RETINOPATHY ON ULTRAWIDE FIELD FLUORESCEIN ANGIOGRAPHY: RECOVERY Study.
    Fan W; Nittala MG; Wykoff CC; Brown DM; Uji A; Hemert JV; Fleming A; Robertson G; Sadda SR; Ip M
    Retina; 2022 Mar; 42(3):426-433. PubMed ID: 34803132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RETINAL LEAKAGE INDEX DYNAMICS ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY IN EYES TREATED WITH INTRAVITREAL AFLIBERCEPT FOR PROLIFERATIVE DIABETIC RETINOPATHY IN THE RECOVERY STUDY.
    Babiuch AS; Wykoff CC; Srivastava SK; Talcott K; Zhou B; Hach J; Hu M; Reese JL; Ehlers JP
    Retina; 2020 Nov; 40(11):2175-2183. PubMed ID: 31917731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DISTINGUISHING INTRARETINAL MICROVASCULAR ABNORMALITIES FROM RETINAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Arya M; Sorour O; Chaudhri J; Alibhai Y; Waheed NK; Duker JS; Baumal CR
    Retina; 2020 Sep; 40(9):1686-1695. PubMed ID: 31613839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
    Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
    Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of diabetic retinopathy with intravitreal Ranibizumab.
    Kernt M; Cserhati S; Seidensticker F; Liegl R; Kampik A; Neubauer A; Ulbig MW; Reznicek L
    Diabetes Res Clin Pract; 2013 Apr; 100(1):e11-3. PubMed ID: 23391744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide Field Swept Source Optical Coherence Tomography Angiography for the Evaluation of Proliferative Diabetic Retinopathy and Associated Lesions: A Review.
    Wang M; Garg I; Miller JB
    Semin Ophthalmol; 2021 May; 36(4):162-167. PubMed ID: 33734945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical Coherence Tomography Angiography in Diabetic Macular Edema Treated with Intravitreal Aflibercept: A 48-Week Observational Study (the DOCTA Study).
    Korobelnik JF; Gaucher D; Baillif S; Creuzot-Garcher C; Kodjikian L; Weber M
    Ophthalmologica; 2023; 246(2):71-80. PubMed ID: 36646050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal panretinal microaneurysm dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study.
    Babiuch A; Wykoff CC; Hach J; Srivastava S; Talcott KE; Yu HJ; Nittala M; Sadda S; Ip MS; Le T; Hu M; Reese J; Ehlers JP
    Br J Ophthalmol; 2021 Aug; 105(8):1111-1115. PubMed ID: 32829304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescein Angiography Indications: Changes after Optical Coherence Tomography and Antiangiogenics.
    Labrador-Velandia SC; Sanabria MR
    Optom Vis Sci; 2018 May; 95(5):435-442. PubMed ID: 29683983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of intravitreal ranibizumab on serous retinal detachment in diabetic macular edema.
    Gündoğdu KÖ; Doğan E; Çelik E; Alagöz G
    J Diabetes Complications; 2022 Jul; 36(7):108228. PubMed ID: 35691875
    [No Abstract]   [Full Text] [Related]  

  • 17. Sequence effect in the treatment of proliferative diabetic retinopathy with intravitreal ranibizumab and panretinal photocoagulation.
    Cao G; Xu X; Wang C; Zhang S
    Eur J Ophthalmol; 2020 Jan; 30(1):34-39. PubMed ID: 30539668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy.
    Kwon SH; Shin JP; Kim IT; Park DH
    Ophthalmology; 2015 May; 122(5):968-75. PubMed ID: 25687026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravitreal injection of human CD34
    Yazdanyar A; Zhang P; Dolf C; Smit-McBride Z; Cary W; Nolta JA; Zawadzki RJ; Marsh-Armstrong N; Park SS
    Exp Eye Res; 2020 Jan; 190():107865. PubMed ID: 31682846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
    Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
    Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.